TSX:4151 1 February 2026

Amgen stock price near $342: AMGN heads into earnings after Kyowa Kirin deal exit

Amgen shares fell 0.3% to $341.88 after the company disclosed plans to exit its eczema drug partnership with Kyowa Kirin. Kyowa Kirin will regain full rights to rocatinlimab, with regulatory submission expected in the first half of 2026. Amgen reports earnings Tuesday after market close.

1 February 2026

Earnings Reports·NASDAQ:AMGN·Stock Market·TSX:4151

ASE Technology Upgraded to Buy by Wall Street Zen Amid Mixed Analyst Ratings
April 5, 2026, 1:42 PM EDT. ASE Technology (NYSE:ASX) saw a rating upgrade from Wall Street Zen, shifting from hold to buy, signaling increased investor confidence. The semiconductor firm's shares opened at $22.27, reflecting a 50-day moving average of $21.96 and a 200-day average of $17.22. Despite beating earnings per share expectations with $0.21 vs. $0.20 estimated, revenue fell short at $5.22 billion against a $5.47 billion forecast. Other analysts remain divided: Zacks Research downgraded ASX to strong sell, while Weiss Ratings maintains a hold. Institutional investors like HSBC and Rockefeller Capital have boosted their stakes recently. ASE Technology holds a $49.39 billion market cap with a price-to-earnings ratio of 38.39, navigating a mixed analyst consensus yet showing earnings resilience.